Press Release: Nimbus Discovery : Nimbus Discovery to Present Data Showing That Selective ACC Inhibitors Dramatically Impact Tumor Growth in Pre-Clinical Models at AACR Annual Meeting 2014
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pr-Clinical Research Shows ACC Inhibitors Dramatically Impact Tumor Growth in Small Cell Lung Cancer and Liver Cancer
Read full article »
Nimbus Discovery, is a biotechnology company using breakthrough in silico technology to develop NCEs against high-value targets.
Read more